Sunshine Biopharma Inc. Cash and Restricted Cash
Sunshine Biopharma Inc. (SBFM) had Cash and Restricted Cash of $13.75 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.75M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.91M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.12M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.31M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $13.75M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.91M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $9.12M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $9.31M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $10.31M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $8.12M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $9.69M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $12.21M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $11.51M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $17.43M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $16.29M 10-K · filed 2026-04-03 |
| 2023-09-30 | $18.85M 10-Q · filed 2024-11-05 |
| 2023-06-30 | $19.73M 10-Q/A · filed 2024-08-20 |
| 2023-03-31 | $19.29M 10-Q · filed 2024-05-20 |
| 2022-12-31 | $21.83M 10-K · filed 2025-04-01 |
| 2022-09-30 | $40.56M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $41.73M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $13.18M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $2.05M 10-K · filed 2024-03-28 |
| 2021-09-30 | $2.39M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $1.74M 10-Q · filed 2022-08-03 |
| 2021-03-31 | $1.80M 10-Q · filed 2022-05-06 |
| 2020-12-31 | $989.89K 10-K · filed 2023-04-04 |
| 2019-12-31 | $40.50K 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |